Biovica International AB (publ) (STO:BIOVIC.B)
0.4210
0.00 (0.00%)
At close: Jan 21, 2026
Biovica International AB Revenue
Biovica International AB had revenue of 2.68M SEK in the quarter ending October 31, 2025, with 15.74% growth. This brings the company's revenue in the last twelve months to 9.89M, up 41.22% year-over-year. In the fiscal year ending April 30, 2025, Biovica International AB had annual revenue of 8.65M with 18.53% growth.
Revenue (ttm)
9.89M
Revenue Growth
+41.22%
P/S Ratio
12.42
Revenue / Employee
412.13K
Employees
27
Market Cap
122.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 8.65M | 1.35M | 18.53% |
| Apr 30, 2024 | 7.30M | 2.08M | 39.99% |
| Apr 30, 2023 | 5.21M | 113.00K | 2.22% |
| Apr 30, 2022 | 5.10M | -2.38M | -31.84% |
| Apr 30, 2021 | 7.48M | -2.20M | -22.71% |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |